Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Will The Anti-Parkinson Drugs Market Valuation Change Between Now And 2029?

The market size of anti-parkinson drugs has seen a robust expansion in the previous years. It is projected to increase from $10.39 billion in 2024 to $10.96 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. The escalated growth during the historical period can be credited to factors such as the aging population, the rise in disease incidence, the development of healthcare infrastructure, and progressive research advancements.

The market for anti-Parkinson medications is projected to see robust expansion in the coming years, with an expectation to reach “$13.48 billion by 2029” and a Compound Annual Growth Rate (CAGR) of 5.3%. The expected growth in the forecast period can be linked to increasing awareness, advancements in biotechnology, and the emergence of new markets. Significant trends anticipated during the forecast period include R&D investment, personalized healthcare, the development of disease-modifying therapies, drug redevelopment, remote telemedicine, biosimilars, and research partnerships.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

What External And Internal Drivers Are Influencing The Anti-Parkinson Drugs Market?

The escalating number of elderly people, coupled with the rising instances of Parkinson’s disease, is anticipated to propel the need for anti-Parkinson drugs in the market. Parkinson’s disease is most commonly found in individuals above the age of 60. As per the World Health Organization’s data from October 2022, it is predicted that globally, by 2030, one in every six individuals will be 60 years or older. By 2050, the global population within this age bracket will have doubled to 2.1 billion. Consequently, the enlarging older population is contributing to the expansion of the anti-parkinson drugs market.

Which Sub-Segments Are Driving Growth Within The Anti-Parkinson Drugs Market?

The anti-parkinson drugs market covered in this report is segmented –

1) By Drugs Class: Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs

2) By Route of Administration: Oral, Injection, Transdermal

3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies

Subsegments:

1) By Levodopa Or Carbidopa: Immediate-Release Levodopa Or Carbidopa, Extended-Release Levodopa Or Carbidopa

2) By Dopamine Receptor Agonists: Pramipexole, Ropinirole, Rotigotine

3) By Monoamine Oxidase Type B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide

4) By Catechol-O-Methyltransferase (COMT)-Inhibitors: Entacapone, Tolcapone

5) By Anticholinergics: Benztropine, Trihexyphenidyl

6) By Other Drugs: Amantadine, Apomorphine

What Future-Focused Trends Are Anticipated In The Anti-Parkinson Drugs Market?

Firms that are prominent players in the anti-Parkinson drugs market concentrate on the creation of cutting-edge therapeutic treatments such as motor fluctuations and dyskinesia, in an effort to improve the management of symptoms and reduce adverse effects. Motor fluctuations and dyskinesia often add complexity to Parkinson’s disease treatment, thus impacting patient health. For instance, PRODUODOPA was launched in January 2024 by AbbVie Inc., an American pharmaceutical firm. This treatment, consisting of foslevodopa/foscarbidopa, is the first 24-hour subcutaneous infusion therapy specifically designed to target severe motor fluctuations and dyskinesia in advanced stages of Parkinson’s disease, when other therapies have been ineffective. It continuously administers levodopa, which could potentially extend ‘on’ periods and enhance the control of symptoms.

Which Players Are Shaping The Competitive Landscape Of The Anti-Parkinson Drugs Market?

Major companies operating in the anti-parkinson drugs market include GlaxoSmithKline plc, Pfizer Inc., Merck Co., Novartis AG, F. Hoffmann-La Roche AG, UCB S.A, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Mylan NV, C.H. Boehringer Sohn AG & Co. KG, Orion Pharma Ltd., ACADIA Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., US WorldMeds LLC, Zydus Lifesciences Limited, Chemical Industrial & Pharmaceutical Laboratories Ltd., Strides Shasun Ltd., Axcan Pharma Inc., Upsher-Smith Laboratories LLC, H. Lundbeck A/S, Vertical Pharmaceuticals LLC, Zambon SPA, M Somerset Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

How Do Regional Dynamics Influence The Anti-Parkinson Drugs Market Performance?

North America was the largest region in the anti-Parkinson drugs market in 2024. Middle East is expected to be the fastest-growing region in the anti-parkinson drugs market during the forecast period. The regions covered in the anti-parkinson drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3462&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model